“…Generally, little to no improvement in facial edema is noted with the use of pharmacological agents, leading many clinicians to pursue more invasive, yet also unreliable, treatments such as blepharoplasty, carbon dioxide laser, and local injections. 6,10,11,13,20,21 There are fewer than a handful of publications documenting the use of oral isotretinoin for the treatment of MD, which was first described by Jansen and Plewig 22 in 1997; however, all publications report its use in combination with oral corticosteroids or antihistamines, and treatment duration has varied from 6 to 16 weeks, with daily dosing between 10 and 50 mg. 5,10,22 Also, these treatment regimens were marked by incomplete or transient improvements in clinical findings 6,10,22,23 ; yet the notable improvement in both facial erythema and edema was indicative of oral isotretinoin as a promising therapeutic option compared with other pharmacological agents. It is possible that the conservative dosing and brief treatment duration documented in these reports contributed to the partial success of isotretinoin therapy for MD.…”